Pursuing cancer elimination one cancer type at a time

Published on: 18 January 2021

For cancer patients, personalised care matters more than ever

Mobile blood draw programs bring comprehensive genetic profiling and personalised care to cancer patients – the hidden victims of the pandemic

Published on: 4 March 2020

Roche Voices

In our Roche blog, find unfiltered opinions and personal stories from our employees on science, healthcare and life.

Published on: 19 November 2020

Data can change your life; it probably already has

How data can improve and save lives, and why it matters during the COVID-19 crisis and beyond.

Published on: 16 November 2020

Ten remarkable facts about making antibody medicines

Antibodies are an important part of our immune system and antibody medicines can help fight diseases. Learn about the complex process needed to make them.

Published on: 16 December 2020

Careers

Find jobs and learn more about exciting career opportunities at Roche, one of the world's leading research-based healthcare companies. Apply online...

Published on: 17 December 2020

3 factors to help decide on the appropriate SARS-CoV-2 test

The broad variety and availability of tests related to SARS-CoV-2 helps manage the Covid-19 pandemic. Choosing the appropriate test depends on three factors.

Published on: 30 October 2020

Finding cancer’s fingerprint

How comprehensive genomic profiling – through tissue and liquid-based approaches – is driving truly personalised cancer care.

Published on: 16 April 2020

Roche COVID-19 response

We are working together with partners in the industry, our customers, NGOs, governments and regulatory bodies to ensure we do all we can to help contain the novel coronavirus.

Published on: 29 June 2020

Diagnostics ABC: all you need to know about diagnostics terms

How much do you know about diagnostics terms? Here’s what you need to know to shine in every discussion about testing.

Published on: 28 April 2020

COVID-19 and the mysterious world of antibodies

Timothy Tellinghuisen, Head of Virology Discovery, explains why understanding antibodies could hold the key in tackling COVID-19 and other pandemics.